Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
Vir Biotechnology is seeking an experienced Senior Director, Clinical Research Oncology Program Executive (PE) to serve as the development team leader and single point of accountability for one or more oncology development programs. This highly visible leadership role sits at the intersection of clinical development, program strategy, and corporate execution.
The Oncology PE will be responsible for defining and driving the overall development strategy, ensuring alignment across functions, and leading cross-functional teams to achieve key development milestones. The individual will partner closely with executive leadership to shape program direction, evaluate risks and opportunities, prioritize investments, and ensure successful execution of Vir Bio’s oncology portfolio.
You will be successful in this role if you bring deep oncology drug development experience and enjoy translating complex scientific and clinical insights into clear development strategies. You are comfortable working across functions, influencing decisions at all levels of the organization, and helping teams navigate key development milestones and strategic decisions.
This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.
WHAT YOU'LL DO- Serve as the cross-functional leader and single point of accountability for one or more oncology development programs
- Define and drive overall program vision, clinical development strategy, key milestones, and integrated development plans
- Lead cross-functional program teams to align on objectives, priorities, timelines, resource needs, and risk mitigation strategies
- Partner with executive leadership and governance committees to support strategic decision-making and portfolio prioritization
- Ensure programs are appropriately resourced and provide oversight and input on major budget and investment decisions
- Leverage deep oncology and clinical development expertise to guide development strategy, clinical trial planning, data interpretation, and key program decisions
- Represent programs at senior leadership meetings, governance reviews, alliance meetings, regulatory interactions, and other external forums
- Mentor and develop team members while helping strengthen program leadership capabilities across the organization
- Own the integrated development plan and target product profile, including stage gates, evidence requirements, and clear go/no-go recommendations.
- Chair the development team, establish decision rights and accountabilities, resolve issues promptly, and escalate material tradeoffs with a recommendation.
- Ensure fit-for-purpose translational medicine, clinical pharmacology, biomarker, companion-diagnostic, and patient-selection strategies from first-in-human development through registration.
- Guide indication prioritization, sequencing, combination strategy, and lifecycle planning based on scientific rationale, unmet need, speed to interpretable data, competitive intensity, regulatory feasibility, and commercial opportunity.
- Define data-readout and evidence-generation plans that support rapid learning, early de-risking, and disciplined investment.
- Partner with Regulatory Affairs on global strategy, health-authority engagement, dose optimization, and expedited-development opportunities supported by data.
- Coordinate Clinical Operations, Biometrics, Safety, CMC/Technical Operations, Medical Affairs, and Commercial to ensure integrated execution, inspection readiness, and a coherent program narrative.
- Maintain integrated financial, timeline, resource, dependency, and risk scenarios; recommend corrective action as assumptions or data change.
- Engage investigators, key opinion leaders, collaborators, and potential partners, incorporating external insights into program strategy.
- Incorporate patient burden, feasibility, diversity, access, and clinically meaningful outcomes into program and study decisions.
- MD or PhD; board certification in Oncology, Hematology/Oncology, or a related specialty preferred
- 15+ years of biotechnology or pharmaceutical industry experience with substantial experience in oncology drug development
- Demonstrated success leading cross-functional development programs in a matrix environment
- Deep understanding of oncology clinical development, including experience across early and late-stage development
- Experience serving as a Medical Director, Clinical Research Physician, Program Team Leader, or comparable development leadership role
- Strong strategic thinking and ability to integrate scientific, clinical, regulatory, operational, and commercial considerations into development plans
- Exceptional executive communication, facilitation, negotiation, and conflict-resolution skills.
- Experience presenting to executive leadership teams, governance committees, boards, and external stakeholders
- Track record of advancing an oncology program through a major value inflection point, such as first-in-human entry, proof of concept, dose selection, pivotal initiation, regulatory submission, or approval.
- Ability to make decisions under uncertainty and communicate the rationale, assumptions, alternatives, and consequences clearly.
- High integrity, sound judgment, enterprise mindset, and accountability for strategy and execution.
- Ability to travel domestically and internationally as needed.
The expected salary range for this position is $235,500 to $329,500 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
Skills Required
- MD or PhD
- Board certification in Oncology, Hematology/Oncology, or a related specialty
- 15+ years of biotechnology or pharmaceutical industry experience
- Substantial experience in oncology drug development
- Demonstrated success leading cross-functional development programs in a matrix environment
- Deep understanding of oncology clinical development across early- and late-stage development
- Experience as a Medical Director, Clinical Research Physician, Program Team Leader, or comparable development leader
- Ability to integrate scientific, clinical, regulatory, operational, and commercial considerations into development plans
- Exceptional executive communication, facilitation, negotiation, and conflict-resolution skills
- Experience presenting to executive leadership teams, governance committees, boards, and external stakeholders
- Track record of advancing an oncology program through a major value inflection point
- Ability to make decisions under uncertainty and clearly communicate rationale, assumptions, alternatives, and consequences
- High integrity, sound judgment, enterprise mindset, and accountability for strategy and execution
- Ability to travel domestically and internationally as needed
- Current authorization to work for any employer in the United States
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™. Join us as we pursue our mission to transform lives. It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
